Windlas Biotech Ltd - 543329 - Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Wednesday, The February 2, 2022
Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2022 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2021 Windlas Biotech Ltd - 543329 - Shareholding for the Period Ended December 31, 2021
Windlas Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Windlas Biotech Ltd - 543329 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBl (Depositories and Participants) Regulations, 2018 for the Quarter ended December 31, 2021. Windlas Biotech Ltd - 543329 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 031310 Name of the Signatory :- Ananta Narayan PandaDesignation :- Company Secretary and Compliance Officer India's API push to fructify in three to five years, says MD at Windlas Biotech
Experts say focus on price and not on Chinese dependence impacting India Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Company appoints Chief Business Officer Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.